Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Pritumumab by Nascent Biotech for Low-Grade Glioma: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Low-Grade Glioma. According to GlobalData, Phase...
Pritumumab by Nascent Biotech for Craniopharyngioma: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Craniopharyngioma. According to GlobalData, Phase I...
Pritumumab by Nascent Biotech for Anaplastic Oligoastrocytoma: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Anaplastic Oligoastrocytoma. According to GlobalData, Phase...
Pritumumab by Nascent Biotech for Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis): Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis)....
Pritumumab by Nascent Biotech for Pituitary Tumor: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Pituitary Tumor. According to GlobalData, Phase...
Pritumumab by Nascent Biotech for Oligodendroglioma: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Oligodendroglioma. According to GlobalData, Phase I...
Pritumumab by Nascent Biotech for Meningioma: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Meningioma. According to GlobalData, Phase I...
Pritumumab by Nascent Biotech for Medulloblastoma: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Medulloblastoma. According to GlobalData, Phase I...
Pritumumab by Nascent Biotech for Chordoma: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Chordoma. According to GlobalData, Phase I...
Pritumumab by Nascent Biotech for Anaplastic Astrocytoma: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Anaplastic Astrocytoma. According to GlobalData, Phase...
Pritumumab by Nascent Biotech for Non-Small Cell Lung Cancer: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Non-Small Cell Lung Cancer. According to...
Pritumumab by Nascent Biotech for Non-Small Cell Lung Cancer: Likelihood of Approval
Pritumumab is under clinical development by Nascent Biotech and currently in Phase I for Non-Small Cell Lung Cancer. According to...